Sunshine Biopharma Inc Warrant
SBFMW
3 hedge funds and large institutions have $5.14K invested in Sunshine Biopharma Inc Warrant in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
54% more capital invested
Capital invested by funds: $3.33K → $5.14K (+$1.8K)
0% more funds holding
Funds holding: 3 → 3 (0)
0.2% less ownership
Funds ownership: 0.27% → 0.07% (-0.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$264 |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$123 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $4.79K | +$123 | +1,255 | +2% |
|
|
2
UBS Group
Zurich,
Switzerland
| $221 | +$264 | +2,684 | +6,882% |
|
|
CS
3
Clear Street
New York
| $131 | – | – | – |
|
SBFMW Hedge Fund Activity: Q2 2024 in Review
3 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q2 2024, worth a combined $5.14K — up 54% from $3.33K a quarter earlier.
Fund positioning in SBFMW was balanced in Q2 2024: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $264.
- 3 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $5.14K of Sunshine Biopharma Inc Warrant stock for Q2 2024, up 54% quarter-over-quarter.
- 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q2 2024 and 0 closed out.
- The largest Sunshine Biopharma Inc Warrant buyer in Q2 2024 was UBS Group, an estimated $264 added.
Based on aggregated 13F filings for Q2 2024.